Kala Bio KALA
NASDAQ KALA
$0.82 -0.02 (-2.39%)
As of: Aug 21, 2026 · 3:58 PM EDT

Kala Bio (KALA) Gross Profit (2019 - 2022)

Kala Bio (KALA) posted Gross Profit of $409000.0 for Q3 2022, up 25.46% sequentially from $326000.0 in Q2 2022, and down 81.06% YoY from $2.2 million in Q3 2021.

Kala Bio (KALA) Gross Profit (2019 - 2022) Analysis & Trends

Kala Bio has reported Gross Profit for 4 years, with the latest figure at $409000.0 in Q3 2022.

  • Quarterly Gross Profit fell 81.06% year-over-year to $409000.0 in Q3 2022, while the trailing twelve-month figure through Dec 2022 was $1.3 million (down 81.35% YoY) and the FY2022 annual result came in at $1.3 million, down 81.35% from the prior year.
  • Gross Profit grew to $409000.0 in Q3 2022 per KALA's latest filing, from $326000.0 in the prior quarter.
  • Over five years, Gross Profit peaked at $2.5 million in Q1 2021 and troughed at $74000.0 in Q2 2020.
  • A 4-year average of $1.0 million and a median of $783000.0 in 2019 frame the typical range for Gross Profit.
  • The sharpest annual moves came in 2020 and 2021: Gross Profit sank 95.66% in 2020, then jumped 2650.0% in 2021.
  • Over 4 years, Gross Profit stood at $433000.0 in 2019, then soared by 103.0% to $879000.0 in 2020, then tumbled by 50.17% to $438000.0 in 2021, then retreated by 6.62% to $409000.0 in 2022.
  • According to Business Quant data, Gross Profit over the past three periods registered $409000.0, $326000.0, and $597000.0 for Q3 2022, Q2 2022, and Q1 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Kala Bio 9.89 Mn 9.89 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2022 409,000.00
Sep 30, 2022 409,000.00
Jun 30, 2022 326,000.00
Jun 30, 2022 326,000.00
Mar 31, 2022 597,000.00
Mar 31, 2022 597,000.00
Dec 31, 2021 438,000.00
Dec 31, 2021 438,000.00
Sep 30, 2021 2.16 Mn
Sep 30, 2021 2.16 Mn
Jun 30, 2021 2.04 Mn
Jun 30, 2021 2.04 Mn
Mar 31, 2021 2.51 Mn
Mar 31, 2021 2.51 Mn
Dec 31, 2020 879,000.00
Dec 31, 2020 879,000.00
Sep 30, 2020 1.52 Mn
Sep 30, 2020 1.52 Mn
Jun 30, 2020 74,000.00
Jun 30, 2020 74,000.00